IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v14y2023i1d10.1038_s41467-023-37175-8.html
   My bibliography  Save this article

Inhibition of lysyl oxidases synergizes with 5-azacytidine to restore erythropoiesis in myelodysplastic and myeloid malignancies

Author

Listed:
  • Qingyu Xu

    (Heidelberg University)

  • Alexander Streuer

    (Heidelberg University)

  • Johann-Christoph Jann

    (Heidelberg University)

  • Eva Altrock

    (Heidelberg University)

  • Nanni Schmitt

    (Heidelberg University)

  • Johanna Flach

    (Heidelberg University)

  • Carla Sens-Albert

    (Heidelberg University)

  • Felicitas Rapp

    (Heidelberg University)

  • Julia Wolf

    (Heidelberg University)

  • Verena Nowak

    (Heidelberg University)

  • Nadine Weimer

    (Heidelberg University)

  • Julia Obländer

    (Heidelberg University)

  • Iris Palme

    (Heidelberg University)

  • Mariia Kuzina

    (Karlsruhe Institute of Technology)

  • Ahmed Jawhar

    (Heidelberg University)

  • Ali Darwich

    (Heidelberg University)

  • Cleo-Aron Weis

    (Heidelberg University)

  • Alexander Marx

    (Heidelberg University)

  • Patrick Wuchter

    (Heidelberg University)

  • Victor Costina

    (Heidelberg University)

  • Evelyn Jäger

    (Heidelberg University)

  • Elena Sperk

    (Heidelberg University)

  • Michael Neumaier

    (Heidelberg University)

  • Alice Fabarius

    (Heidelberg University)

  • Georgia Metzgeroth

    (Heidelberg University)

  • Florian Nolte

    (Heidelberg University)

  • Laurenz Steiner

    (Heidelberg University)

  • Pavel A. Levkin

    (Karlsruhe Institute of Technology
    Karlsruhe Institute of Technology)

  • Mohamad Jawhar

    (Heidelberg University)

  • Wolf-Karsten Hofmann

    (Heidelberg University)

  • Vladimir Riabov

    (Heidelberg University)

  • Daniel Nowak

    (Heidelberg University)

Abstract

Limited response rates and frequent relapses during standard of care with hypomethylating agents in myelodysplastic neoplasms (MN) require urgent improvement of this treatment indication. Here, by combining 5-azacytidine (5-AZA) with the pan-lysyl oxidase inhibitor PXS-5505, we demonstrate superior restoration of erythroid differentiation in hematopoietic stem and progenitor cells (HSPCs) of MN patients in 20/31 cases (65%) versus 9/31 cases (29%) treated with 5-AZA alone. This effect requires direct contact of HSPCs with bone marrow stroma components and is dependent on integrin signaling. We further confirm these results in vivo using a bone marrow niche-dependent MN xenograft model in female NSG mice, in which we additionally demonstrate an enforced reduction of dominant clones as well as significant attenuation of disease expansion and normalization of spleen sizes. Overall, these results lay out a strong pre-clinical rationale for efficacy of combination treatment of 5-AZA with PXS-5505 especially for anemic MN.

Suggested Citation

  • Qingyu Xu & Alexander Streuer & Johann-Christoph Jann & Eva Altrock & Nanni Schmitt & Johanna Flach & Carla Sens-Albert & Felicitas Rapp & Julia Wolf & Verena Nowak & Nadine Weimer & Julia Obländer & , 2023. "Inhibition of lysyl oxidases synergizes with 5-azacytidine to restore erythropoiesis in myelodysplastic and myeloid malignancies," Nature Communications, Nature, vol. 14(1), pages 1-17, December.
  • Handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-37175-8
    DOI: 10.1038/s41467-023-37175-8
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-023-37175-8
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/s41467-023-37175-8?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Johann-Christoph Jann & Maximilian Mossner & Vladimir Riabov & Eva Altrock & Nanni Schmitt & Johanna Flach & Qingyu Xu & Verena Nowak & Julia Obländer & Iris Palme & Nadine Weimer & Alexander Streuer , 2021. "Bone marrow derived stromal cells from myelodysplastic syndromes are altered but not clonally mutated in vivo," Nature Communications, Nature, vol. 12(1), pages 1-11, December.
    2. Ozge Saatci & Aysegul Kaymak & Umar Raza & Pelin G. Ersan & Ozge Akbulut & Carolyn E. Banister & Vitali Sikirzhytski & Unal Metin Tokat & Gamze Aykut & Suhail A. Ansari & Hayriye Tatli Dogan & Mehmet , 2020. "Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer," Nature Communications, Nature, vol. 11(1), pages 1-17, December.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Jonathan J. Swietlik & Stefanie Bärthel & Chiara Falcomatà & Diana Fink & Ankit Sinha & Jingyuan Cheng & Stefan Ebner & Peter Landgraf & Daniela C. Dieterich & Henrik Daub & Dieter Saur & Felix Meissn, 2023. "Cell-selective proteomics segregates pancreatic cancer subtypes by extracellular proteins in tumors and circulation," Nature Communications, Nature, vol. 14(1), pages 1-17, December.
    2. Ozge Saatci & Metin Cetin & Meral Uner & Unal Metin Tokat & Ioulia Chatzistamou & Pelin Gulizar Ersan & Elodie Montaudon & Aytekin Akyol & Sercan Aksoy & Aysegul Uner & Elisabetta Marangoni & Mathew S, 2023. "Toxic PARP trapping upon cAMP-induced DNA damage reinstates the efficacy of endocrine therapy and CDK4/6 inhibitors in treatment-refractory ER+ breast cancer," Nature Communications, Nature, vol. 14(1), pages 1-20, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-37175-8. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.